Company

Third Harmonic Bio

Biotechnology Research United States 34 employees

Employees: 34
Contacts: 2
Emails: 2
Phones: 2

thirdharmonicbio.com LinkedIn Crunchbase

Third Harmonic Bio Overview

Headquarters: United States
Website: thirdharmonicbio.com
Industry: Biotechnology Research
Employees: 34
Founded: 2019
Funding: 105.0M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Third Harmonic Bio

Third Harmonic Bio is a clinical-stage biopharmaceutical company developing a highly selective, oral KIT inhibitor for treatment of dermal, respiratory and gastrointestinal inflammatory diseases. KIT is a cell surface receptor that acts as the master survival and functional regulator of mast cells, which are immune cells concentrated at the body’s interfaces with the external environment and that act as the key mediator of the inflammation associated with mast-cell mediated inflammatory diseases. By inhibiting KIT, we believe we can provide broad symptomatic relief to patients with a range of disorders, including chronic spontaneous urticaria and severe asthma.

Third Harmonic Bio Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 2; 50.0% coverage

Third Harmonic Bio Org Chart

Sample employees and titles

Name	Title	Location	Contact
Tom Soloway	Chief Executive Officer at T-knife	San Francisco, California, United States	Email Phone
Jacki Lafrance	Quality Leader - Biotech Executive	Westport, Massachusetts, United States	Email Phone
Natalie Holles	CEO at Third Harmonic Bio		View
Joshua Giguere	Director, Cmc Drug Substance		View